Biocytogen just stacked two cancer bets in three days. Is its platform strategy starting to compound?
SK pharmteco alliance with Prozomix reflects rising CDMO demand for enzyme-driven synthesis platforms
Can SAGA Metals Corp. turn a Rio Tinto castoff into Quebec’s next titanium discovery story? (TSXV: SAGA)
Read More 3 minute read Healthcare Industry News FDA grants breakthrough device designation to Acrivon’s OncoSignature assay for endometrial cancer Acrivon Therapeutics has secured a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its… byPallavi MadhirajuFebruary 5, 2025